EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aspirin or non‐steroidal anti‐inflammatory drug initiation and subsequent bladder cancer evaluation

Malene Söth Hansen iD, Lars Dyrskjøt, Uffe Heide-Jørgensen iD, Jørgen Bjerggaard Jensen, Mette Nørgaard iD

Journal of Internal Medicine · 2026

DOI: 10.1111/joim.70115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Internal Medicine, 2026. Verfasst von Malene Söth Hansen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danish Cancer Society, Kræftens Bekæmpelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Whether aspirin or non‐aspirin non‐steroidal anti‐inflammatory drugs (NSAIDs) initiation may unmask unknown bladder cancers (BCs) by hematuria remains controversial.

Objectives

To evaluate unmasking, we compared cystoscopy rates, BC prevalence at cystoscopy, and invasive stage prevalence at diagnosis in aspirin or NSAID initiators with never‐users.

Methods

Using the Danish population‐based registries, we identified all new aspirin or NSAID users in 2005–2023 and a matched never‐using comparison cohort. Second, we identified all first‐time cystoscopy recipients in 2005–2022 with aspirin or NSAID initiation within 1 year prior or never‐use in 10 years preceding cystoscopy. Comparing these groups, we computed hazard ratios of cystoscopy during 1‐year follow‐up, prevalence ratios of BC at cystoscopy, and invasive stage disease at diagnosis.

Results

Among 50,771 aspirin initiators (median age: 67 years, 51% men) and 156,191 NSAID initiators (age: 45 years, 50% men) adjusted hazard ratios of cystoscopy were 1.54 (95% confidence interval [CI]: 1.38–1.72) and 1.56 (95% CI: 1.43–1.70) compared with never‐users. Cystoscopy recipients included 683 aspirin (age: 70 years, 69% men) and 1414 NSAID initiators (age: 60 years, 63% men); standardized morbidity ratio weighted (SMRW) prevalence ratios were 0.97 (95% CI, 0.76–1.22) and 0.65 (95% CI, 0.51–0.82) compared with never‐users. The SMRW invasive stage prevalence ratios were 0.81 (95% CI, 0.63–1.03) and 1.07 (95% CI, 0.85–1.34) in the aspirin and NSAID comparison.

Conclusion

The combination of more cystoscopies and a lower prevalence of invasive stage at BC diagnosis may suggest the unmasking of asymptomatic BC in aspirin initiators. We did not find indications of unmasking with NSAID initiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalAspirinUrinary Bladder NeoplasmsHumansFemaleCystoscopyAgedMaleDenmarkMiddle AgedRegistriesPrevalenceHematuria

Stichwörter der Autor:innen

NSAIDaspirinbladder cancercancer early diagnosiscystoscopy

Substanzen

Anti-Inflammatory Agents, Non-SteroidalAspirin

Autor:innen und Institutionen

  • Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Urology, Aarhus University Hospital, Aarhus, Denmark.

ORCID-Profile: Malene Söth Hansen, Uffe Heide-Jørgensen, Mette Nørgaard

Förderung

  • Danish Cancer Society
  • Kræftens Bekæmpelse

Zitieren

APA

Hansen, M. S., Dyrskjøt, L., Heide-Jørgensen, U., Jensen, J. B., & Nørgaard, M. (2026). Aspirin or non‐steroidal anti‐inflammatory drug initiation and subsequent bladder cancer evaluation. Journal of Internal Medicine. https://doi.org/10.1111/joim.70115

Vancouver

Hansen MS, Dyrskjøt L, Heide-Jørgensen U, Jensen JB, Nørgaard M. Aspirin or non‐steroidal anti‐inflammatory drug initiation and subsequent bladder cancer evaluation. Journal of Internal Medicine. 2026. doi:10.1111/joim.70115

BibTeX
@article{Hansen2026,
  author = {Hansen, Malene Söth and Dyrskjøt, Lars and Heide-Jørgensen, Uffe and Jensen, Jørgen Bjerggaard and Nørgaard, Mette},
  title = {Aspirin or non‐steroidal anti‐inflammatory drug initiation and subsequent bladder cancer evaluation},
  journal = {Journal of Internal Medicine},
  year = {2026},
  doi = {10.1111/joim.70115}
}
Kostenlos starten →